Literature DB >> 22753419

Simple and multistate survival curves: can people learn to use them?

Tim Rakow1, Rebecca J Wright1, Catherine Bull2, David J Spiegelhalter3.   

Abstract

UNLABELLED: OBJECTIVE AND SAMPLE: This investigation assessed the comprehension of survival curves in a community sample of 88 young and middle-aged adults when several aspects of good practice for graphical communication were implemented, and it compared comprehension for alternative presentation formats. DESIGN, METHOD, and MEASUREMENTS: After reading worked examples of using survival curves that provided explanation and answers, participants answered questions on survival data for pairs of treatments. Study 1 compared presenting survival curves for both treatments on the same figure against presentation via 2 separate figures. Study 2 compared presenting data for 3 possible outcome states via a single "multistate" figure for each treatment against presenting each outcome on a separate figure (with both treatments on the same figure). Both studies compared alternative forms of questioning (e.g., "number alive" versus "number dead"). Numeracy levels (self-rated and objective measures) were also assessed.
RESULTS: Comprehension was generally good--exceeding 90% correct answers on half the questions--and was similar across alternative graphical formats. Lower accuracy was observed for questions requiring a calculation but was significantly lower only when the requirement for calculation was not explicit (13%-28% decrements in performance). In study 1, this effect was most acute for those with lower levels of numeracy. Subjective (self-rated) numeracy and objective (measured) numeracy were both moderate positive predictors of overall task accuracy (r ≈ 0.3).
CONCLUSIONS: A high degree of accuracy in extracting information from survival curves is possible, as long as any calculations that are required are made explicit (e.g., finding differences between 2 survival rates). Therefore, practitioners need not avoid using survival curves in discussions with patients, although clear and explicit explanations are important.

Entities:  

Mesh:

Year:  2012        PMID: 22753419     DOI: 10.1177/0272989X12451057

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

Review 1.  Different Measures, Different Outcomes? A Systematic Review of Performance-Based versus Self-Reported Measures of Health Literacy and Numeracy.

Authors:  Eric S Kiechle; Stacy Cooper Bailey; Laurie A Hedlund; Anthony J Viera; Stacey L Sheridan
Journal:  J Gen Intern Med       Date:  2015-04-28       Impact factor: 5.128

2.  Should Health Numeracy Be Assessed Objectively or Subjectively?

Authors:  James G Dolan; Olena A Cherkasky; Qinghua Li; Nancy Chin; Peter J Veazie
Journal:  Med Decis Making       Date:  2015-05-06       Impact factor: 2.583

3.  Effect of different visual presentations on the comprehension of prognostic information: a systematic review.

Authors:  Eman Abukmail; Mina Bakhit; Chris Del Mar; Tammy Hoffmann
Journal:  BMC Med Inform Decis Mak       Date:  2021-08-25       Impact factor: 2.796

4.  Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.

Authors:  Ruth H Keogh; Rhonda Szczesniak; David Taylor-Robinson; Diana Bilton
Journal:  J Cyst Fibros       Date:  2018-01-06       Impact factor: 5.482

5.  Dynamic Prediction of Survival in Cystic Fibrosis: A Landmarking Analysis Using UK Patient Registry Data.

Authors:  Ruth H Keogh; Shaun R Seaman; Jessica K Barrett; David Taylor-Robinson; Rhonda Szczesniak
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

6.  Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information.

Authors:  Ruth H Keogh; Diana Bilton; Rebecca Cosgriff; Dominic Kavanagh; Oliver Rayner; Philip M Sedgwick
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.